CLODEW

Serial Number 90696094
Registration 6717900
700

Registration Progress

Application Filed
May 7, 2021
Under Examination
Approved for Publication
Feb 15, 2022
Published for Opposition
Feb 15, 2022
Registered
May 3, 2022

Trademark Image

CLODEW

Basic Information

Serial Number
90696094
Registration Number
6717900
Filing Date
May 7, 2021
Registration Date
May 3, 2022
Published for Opposition
February 15, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 3, 2022
Registration
Registered
Classes
005

Rights Holder

DAEWOONG PHARMACEUTICAL CO., LTD.

03
Address
35-14, Jeyakgongdan 4-gil
Hyangnam-eup, Hwaseong-si
Gyeonggi-do 18623
KR

Ownership History

DAEWOONG PHARMACEUTICAL CO., LTD.

Original Applicant
03
Gyeonggi-do KR

DAEWOONG PHARMACEUTICAL CO., LTD.

Owner at Publication
03
Gyeonggi-do KR

DAEWOONG PHARMACEUTICAL CO., LTD.

Original Registrant
03
Gyeonggi-do KR

Legal Representation

Attorney
John M. Kim

USPTO Deadlines

Next Deadline
836 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220503)
Due Date
May 03, 2028
Grace Period Ends
November 03, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

8 events
Date Code Type Description Documents
May 3, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 15, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 15, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 26, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 12, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 12, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 9, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 11, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Botulinum toxin for medical use for use in the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction and pelvic pain; Pharmaceutical preparations, namely, acne medications, acne treatment preparations, adrenal hormone preparations, alcohol for topical use, allergy and allergy relief medications, analgesics, androgen preparations, anesthetics for surgical and non-surgical use, antacids, bactericides, antiarrhythmics, antibiotics, anticoagulants, anticonvulsants, antidepressants, antidiabetic preparations, antivirals, anti-cancer preparations, anti-infectives, anti-inflammatories, antipyretics, antibacterial pharmaceuticals, calcium channel blockers, beta blockers, chemical compounds for drug delivery, eye drops, eye patches for medical purposes, hair growth stimulants, vaccines, vaccine adjuvants, vaccine stabilizers, diuretics, amino acids for medical purposes; Medicines for the treatment of gastrointestinal diseases; chemical preparations for pharmaceutical purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, and pelvic pain; chemico-pharmaceutical preparations for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, and pelvic pain; drugs for medical purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, and pelvic pain; Medicines for human purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, and pelvic pain; pharmaceutical preparations for activating cellular function; Adjuvants for medical purposes; pharmaceutical preparations for central nerve treatment, namely, for the treatment of sequelae caused by damage to the central nerve in the brain; dermatological pharmaceutical products, namely, injectable botulinum toxin for refining wrinkles; pharmaceutical preparations for treating skin disorders; antibiotic preparations; pharmaceutical preparations for chemical disorder treatment, namely, for treatment of chemical imbalance in the brain

Classification

International Classes
005